The 2000 burkitt lymphoma trial in Malawi

Pediatric Blood and Cancer

Volumn 44, Issue 3, 2005, Pages 245-250

  Hesseling, Peter ^a   Broadhead, Robin ^b   Mansvelt, Erna ^a   Louw, Mercia ^a   Wessels, Glynn ^a   Borgstein, Eric ^b   Schneider, Johann ^a   Molyneux, Elizabeth ^b  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b UNIVERSITY OF MALAWI   (Malawi)

Author keywords

Burkitt lymphoma; Outcome; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; HYDROCORTISONE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ABDOMEN; ADOLESCENT; ARTICLE; ASPIRATION BIOPSY; BODY SURFACE; BONE MARROW; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; BURKITT LYMPHOMA; CANCER STAGING; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG DOSE REGIMEN; ENZYME LINKED IMMUNOSORBENT ASSAY; FACE; FEMALE; HEMOGLOBIN DETERMINATION; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; KIDNEY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALARIA; MALAWI; MALE; MATHEMATICAL COMPUTING; PARAPLEGIA; PATIENT SELECTION; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; RELAPSE; SEX DIFFERENCE; SIDE EFFECT; SMEAR; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; MALAWI; MALE; METHOTREXATE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDNISONE; VINCRISTINE;

EID: 13444278484     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20254     Document Type: Article

References (11)

1. Patte C, Auperin A, Michon J, et al. The Societe Francaise d'Oncologie Pediatrique LMB89 Protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukaemia. Blood 2001;97:3370-3379.
2. Reiter A, Schrappe P, Tieman M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin Frankfort Munster Group Trial NHL-BFM 90. Blood 1999;94:3294-3306.
3. Magrath I, Adde A, Shad A, et al. Adults and children with small non-cleaved cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 1996;14:925-934.
4. Parkin DM, Kramarova E, Draper GJ, et al., editors. International incidence of childhood cancer vol. 2, IARC scientific publications no. 144; 1998; 34.
5. Hesseling PB, Wessels G. Resources to manage childhood cancer in Africa: An analysis of scholarship applications for the 1994 SIOP Continental Africa meeting. Med Pediatr Oncol 1995;25:260 (abstract).
6. Olweny CLM, Katongole-Mbidde E, Otim D, et al. Long term experience with Burkitt's lymphoma in Uganda. Int J Cancer 1980;26:261-266.
7. Nkrumah FK, Perkins IV. Burkitt's lymphoma. A clinical study of 110 patients. Cancer 1976;37:671-676.
8. Wessels G, Hesseling P. High dose chemotherapy in South African children with B-cell lymphoma: Morbidity, supportive measures, and outcome. Med Pediatr Oncol 2000;34:143-146.
9. Hesseling PB, Broadhead R, Molyneux E, et al. Malawi Pilot Study of Burkitt's lymphoma treatment. Med Pediatr Oncol 2003;41:532-540.
10. Burkitt D, Hutt MSR, Wright DH. The African lymphoma. Preliminary observations on response to chemotherapy. Cancer 1965;18:399-410.
11. Kazembe P, Hesseling PB, Griffin BE, et al. Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy. Med Pediatr Oncol 2003;40:23-25.